(vär′məs), Harold Eliot Born 1939.
American microbiologist. He shared a 1989 Nobel Prize for discovering a sequence of genes that can cause cancer when mutated.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
References in periodicals archive ?
"Our system should enable further studies of the progression of these early-stage tumors into invasive SCLCs that resemble the more aggressive cancers found in patients," said Harold Varmus, co-lead author.
A little over 16 years ago, I was involved with a group (including Harold Varmus and David Lipman of NIH, and researchers Mike Eisen, Patrick Brown, Paul Ginsparg and others) in initiating an alternative publishing model now known as open access.
"Optimizing policies that encourage scientific openness while in appropriate cases limiting the dissemination of research results that might be misused is a difficult challenge," said Harold Varmus, professor at Weill Cornell Medicine, and co-chair of the committee that wrote the report.
Varmus, "A member of the frizzled protein family mediating axis induction by Wnt-5A," Science, vol.
Harold Varmus, a former NIH director and now a professor at Weill Cornell Medical College, says one of the big "lost opportunities" in cancer genomics is how few patients are having it done.
Nobel Prize winner Varmus stepping down as director of NIH's National Cancer Institute, joining Weill Cornell.
Based on this premise, Alberts called for a reconsideration of that policy, a plea recently reiterated in the highly cited July 1, 2014, Proceedings of the National Academy of Sciences article that Alberts co-authored with Harold Varmus, Shirley Tilghman, and Mark Kirschner.
Harold Varmus for his leadership of the National Cancer Institute (NCI) over the past five years.
In the first place must always stand customers (Lendel, Varmus 2012).
Collins and National Cancer Institute Director Harold Varmus, who both have key leadership roles.
An April article in Proceedings of the National Academy of Sciences by four prominent science executives--former Academy president Bruce Alberts, former Princeton University president Shirley Tilghman, director of the National Cancer Institute Harold Varmus, and systems biologist Marc Kirschner of Harvard Medical School--outlined the situation.